ArticleInternational journal of clinical and experimental pathology2020

Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.

Zhijiao Duan et al.PubMed ↗Full text ↗

No numbers read from the abstract.